41,602 Shares in Simulations Plus, Inc. (NASDAQ:SLP) Purchased by Values First Advisors Inc.

Values First Advisors Inc. purchased a new position in Simulations Plus, Inc. (NASDAQ:SLP) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 41,602 shares of the technology company’s stock, valued at approximately $1,862,000. Simulations Plus makes up 1.1% of Values First Advisors Inc.’s portfolio, making the stock its 27th biggest holding.

Several other institutional investors also recently modified their holdings of SLP. Tributary Capital Management LLC bought a new stake in Simulations Plus during the 4th quarter valued at about $9,190,000. Kopion Asset Management LLC increased its stake in Simulations Plus by 145.0% during the 4th quarter. Kopion Asset Management LLC now owns 122,709 shares of the technology company’s stock valued at $5,491,000 after purchasing an additional 72,622 shares in the last quarter. Trexquant Investment LP bought a new stake in Simulations Plus during the 3rd quarter valued at about $1,094,000. Kornitzer Capital Management Inc. KS bought a new stake in Simulations Plus during the 3rd quarter valued at about $813,000. Finally, ProVise Management Group LLC bought a new stake in Simulations Plus during the 3rd quarter valued at about $904,000. 78.08% of the stock is currently owned by institutional investors.

Simulations Plus Stock Performance

Shares of SLP stock traded down $0.20 during trading hours on Friday, reaching $41.15. The company had a trading volume of 69,064 shares, compared to its average volume of 99,376. The business has a fifty day moving average price of $41.32 and a 200-day moving average price of $40.44. Simulations Plus, Inc. has a one year low of $32.69 and a one year high of $52.69. The firm has a market cap of $821.77 million, a PE ratio of 77.64 and a beta of 0.73.

Simulations Plus (NASDAQ:SLP) last announced its quarterly earnings results on Wednesday, January 3rd. The technology company reported $0.10 EPS for the quarter, hitting analysts’ consensus estimates of $0.10. Simulations Plus had a net margin of 17.12% and a return on equity of 8.18%. The firm had revenue of $14.50 million during the quarter, compared to analyst estimates of $13.94 million. During the same period in the previous year, the business posted $0.06 earnings per share. The business’s revenue for the quarter was up 21.2% on a year-over-year basis. Equities research analysts forecast that Simulations Plus, Inc. will post 0.67 EPS for the current year.

Simulations Plus Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, February 5th. Stockholders of record on Monday, January 29th were paid a $0.06 dividend. The ex-dividend date of this dividend was Friday, January 26th. This represents a $0.24 dividend on an annualized basis and a dividend yield of 0.58%. Simulations Plus’s dividend payout ratio is presently 45.28%.

Insider Buying and Selling

In related news, Director Walter S. Woltosz sold 20,000 shares of the firm’s stock in a transaction that occurred on Tuesday, January 2nd. The shares were sold at an average price of $44.46, for a total value of $889,200.00. Following the transaction, the director now owns 3,659,403 shares of the company’s stock, valued at $162,697,057.38. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. In other Simulations Plus news, Director Walter S. Woltosz sold 20,000 shares of Simulations Plus stock in a transaction that occurred on Tuesday, January 2nd. The shares were sold at an average price of $44.46, for a total transaction of $889,200.00. Following the transaction, the director now owns 3,659,403 shares of the company’s stock, valued at $162,697,057.38. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Walter S. Woltosz sold 18,945 shares of Simulations Plus stock in a transaction that occurred on Thursday, February 1st. The shares were sold at an average price of $38.02, for a total transaction of $720,288.90. Following the transaction, the director now directly owns 3,641,250 shares in the company, valued at approximately $138,440,325. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 39,945 shares of company stock valued at $1,653,229. 20.90% of the stock is owned by insiders.

Analysts Set New Price Targets

Separately, Craig Hallum raised their price objective on shares of Simulations Plus from $50.00 to $51.00 and gave the company a “buy” rating in a research note on Thursday, January 4th.

Simulations Plus Company Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.